Oncology

Papers
(The H4-Index of Oncology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Recurrence Pattern Comparing Preoperative Chemoradiotherapy and Preoperative Chemotherapy with Docetaxel plus 5-Fluorouracil and Cisplatin for Advanced Esophageal Cancer24
Efficacy and Safety of the Combination of Nano-Liposomal Irinotecan and 5-Fluorouracil/L-Leucovorin in Unresectable Advanced Pancreatic Cancer: A Real-World Study23
Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors19
Alpha-2-Macroglobulin Is a Novel Anticancer Agent18
Updates and Review of Neoadjuvant Therapy for Resectable Pancreatic Cancer17
Predictive Ability of Rule of 3 in Parathyroid Cancer: Outcomes from a South Asian Cohort16
Lenvatinib Might Induce Activation of Host Immunity in Patients with Hepatocellular Carcinoma16
Skin Cancer Detection in Diverse Skin Tones by Machine Learning Combining Audio and Visual Convolutional Neural Networks13
Atezolizumaba plus bevacizumab is Associated with Favorable Overall Survival Over Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma13
Front & Back Matter13
The utility of the new category by number of stations for lymph nodal involvement in non-small cell lung cancer13
Retacrit®, Biosimilar of Epoetin Alfa, in Chemotherapy-Induced Anemia in Routine Practice: Impact of Iron Supplementation12
Polymorphism in Thymidylate Synthase Gene Predicts Survival and Toxicity in North Indian Lung Cancer Patients Undergoing Platinum-Based Doublet Chemotherapy12
Front & Back Matter12
0.092042207717896